Publication: First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment
No Thumbnail Available
Date
2014-07-01T00:00:00Z
Authors
Authors
Ozaras, Resat
Mete, Bilgul
Ceylan, Bahadir
Ozgunes, Nail
Gunduz, Alper
Karaosmanoglu, Hayat
Cagatay, Atahan
Gokturk, Kadir
Erdem, Levent
Kocak, Funda
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Background Hepatitis B virus (HBV) infection is a health problem worldwide. Current treatment options for chronic hepatitis B (CHB) are nucleoside or nucleotide analogues and pegylated interferons. Tenofovir and entecavir are much more commonly used as they have better efficacy, tolerability, and high genetic barriers to resistance.
Description
Keywords
Citation
Ozaras R., Mete B., Ceylan B., Ozgunes N., Gunduz A., Karaosmanoglu H., Cagatay A., Gokturk K., Erdem L., Kocak F., et al., -First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment-, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.26, ss.774-780, 2014